Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer

Published:2010-12-02 Issue:1 Volume:2 Page:109-117
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:en
Short-container-title:

Author:

YAMADA AKIRA,NOGUCHI MASANORI,KOMATSU NOBUKAZU,SUEKANE SHIGETAKA,YUTANI SHIGERU,MORIYA FUKUKO,MINE TAKASHI,MOMOZONO KOSUKE,KAWANO KOICHIRO,ITOH KYOGO

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches;Medical Hypotheses;2019-09

2. A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival;International Journal of Cancer;2018-12-05

3. In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity;PLOS ONE;2017-08-02

4. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants;Expert Review of Vaccines;2013-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP